256 related articles for article (PubMed ID: 8838759)
1. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
[TBL] [Abstract][Full Text] [Related]
2. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
3. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
[TBL] [Abstract][Full Text] [Related]
4. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease.
Sharp CK; Zeligman BE; Johnson AM; Duley I; Gabow PA
Am J Kidney Dis; 1999 Nov; 34(5):863-8. PubMed ID: 10561142
[TBL] [Abstract][Full Text] [Related]
6. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
7. Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)?
Geberth S; Ritz E; Zeier M; Stier E
Nephrol Dial Transplant; 1995; 10(9):1603-6. PubMed ID: 8559477
[TBL] [Abstract][Full Text] [Related]
8. [Hepatic polycystic disease is not always associated with polycystic kidney: epidemiological data].
Simon P; Ang KS; Charasse C; Ghali N; Catroux B; Houitte H
Rev Med Interne; 1993; 14(10):1037. PubMed ID: 8009032
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.
Kelleher CL; McFann KK; Johnson AM; Schrier RW
Am J Hypertens; 2004 Nov; 17(11 Pt 1):1029-34. PubMed ID: 15533729
[TBL] [Abstract][Full Text] [Related]
10. [Genetic heterogeneity and phenotypes of autosomal dominant polycystic kidney disease in Chinese Han nationality].
Zhang WL; Mei CL
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(22):1516-21. PubMed ID: 16854275
[TBL] [Abstract][Full Text] [Related]
11. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
[TBL] [Abstract][Full Text] [Related]
12. Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.
Tazón-Vega B; Vilardell M; Pérez-Oller L; Ars E; Ruiz P; Devuyst O; Lens X; Fernández-Llama P; Ballarín J; Torra R
Nephrol Dial Transplant; 2007 Jun; 22(6):1567-77. PubMed ID: 17303584
[TBL] [Abstract][Full Text] [Related]
13. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
14. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease.
Stefanakis N; Ziroyiannis P; Trygonis S; Lamnissou K
Nephron Clin Pract; 2008; 110(2):c101-6. PubMed ID: 18815450
[TBL] [Abstract][Full Text] [Related]
15. PKD2 mutations in a Czech population with autosomal dominant polycystic kidney disease.
Stekrová J; Reiterová J; Merta M; Damborsky J; Zidovská J; Kebrdlová V; Kohoutová M
Nephrol Dial Transplant; 2004 May; 19(5):1116-22. PubMed ID: 14993477
[TBL] [Abstract][Full Text] [Related]
16. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
Walker D; Consugar M; Slezak J; Rossetti S; Torres VE; Winearls CG; Harris PC
Am J Kidney Dis; 2003 Jan; 41(1):90-4. PubMed ID: 12500225
[TBL] [Abstract][Full Text] [Related]
17. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
Gonçalves S; Guerra J; Santana A; Abreu F; Mil-Homens C; Gomes da Costa A
Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
[TBL] [Abstract][Full Text] [Related]
18. [Clinical, genetic and molecular studies on autosomal dominant polycystic kidney disease].
Torra R; Badenas C; Darnell A; Nicolau C; Volpini V; Revert L; Estivill X
Med Clin (Barc); 1998 Apr; 110(13):481-7. PubMed ID: 9611728
[TBL] [Abstract][Full Text] [Related]
19. Favorable graft survival in renal transplant recipients with polycystic kidney disease.
Johnston O; O'Kelly P; Donohue J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Ren Fail; 2005; 27(3):309-14. PubMed ID: 15957548
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological and molecular study of autosomal dominant polycystic kidney disease (ADPKD) in the province of Vicenza, Italy: possible founder effect?].
Corradi V; Gastaldon F; Virzi' GM; Clementi M; Nalesso F; Cruz DN; de Cal M; Torregrossa R; Ronco C
G Ital Nefrol; 2010; 27(6):655-63. PubMed ID: 21132648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
